NVZMF · NOVOZYMES AS/FI · Analyst Estimates
Market Cap
$30.70B
Shares
466.25M
Analyst Estimates
Compare analyst forecasts for NOVOZYMES AS/FI across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-09-18 15:11 UTC · Publication dates shown per estimate · 8 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count |
|---|---|---|---|---|
|
Revenue
DKK
Publication date not stated |
33232144000
|
33449663430
|
33802099000
|
— |
|
Revenue
analysts
Publication date not stated |
— | — | — |
12
|
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count |
|---|---|---|---|---|
|
Revenue
DKK
Publication date not stated |
35232262000
|
35874424640
|
36616699000
|
— |
|
Revenue
analysts
Publication date not stated |
— | — | — |
14
|
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count |
|---|---|---|---|---|
|
Revenue
DKK
Publication date not stated |
8511038000
|
8552136500
|
8593235000
|
— |
|
Revenue
analysts
Publication date not stated |
— | — | — |
2
|
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count |
|---|---|---|---|---|
|
Revenue
DKK
Publication date not stated |
7958083000
|
8129947500
|
8301812000
|
— |
|
Revenue
analysts
Publication date not stated |
— | — | — |
2
|